Latest Amplia Therapeutics (ASX:ATX) News
Page 2
Page 2 of 4
Healthcare Wrap - Week 19 (4 May -> 8 May) 2026
9 May 2026
Amplia and ANZGOG Launch PRROSE Trial Targeting Resistant Ovarian Cancer
8 May 2026
Healthcare Wrap - Week 18 (27 Apr -> 1 May) 2026
2 May 2026
Amplia’s Narmafotinib Shows Survival Gains and Manufacturing Scale-Up
28 Apr 2026
Market Wrap - Week 13 (23 Mar -> 27 Mar) 2026
28 Mar 2026
Healthcare Wrap - Week 13 (23 Mar -> 27 Mar) 2026
28 Mar 2026
Amplia’s Narmafotinib Shows Breakthrough Results in Pancreatic Cancer Trial
23 Mar 2026
Healthcare Wrap - Week 5 (26 Jan -> 30 Jan) 2026
31 Jan 2026
Amplia’s Pancreatic Cancer Drug Shows 35% Response Rate, FDA Backs Dose Plan
30 Jan 2026
Amplia Therapeutics Raises $27.6M Amid Promising Pancreatic Cancer Trial Results
27 Nov 2025
Amplia Therapeutics Gains FDA Backing for Pivotal Pancreatic Cancer Trial
20 Nov 2025
Amplia Therapeutics Advances Pancreatic Cancer Drug with New Trial and Patent Win
29 Oct 2025